Cancer immunotherapy biotech Tessa Therapeutics names industry veteran to board

IN a sign that it could be progressing towards certain milestones, Singapore-based immunotherapy biotech company Tessa Therapeutics continued to shore up its board of directors with another independent member on Friday.

In April 2018, the company appointed former Novo Nordisk chairman Goran Ando to the board. This was followed in December 2018 with the appointment of Dr George Sledge, chief of medical oncology at Stanford University Medical Centre. Tessa counts Singapore government-owned investment firm Temasek Holdings as an investor. In 2017, Temasek led a US$80 million funding round into Tessa, alongside Heliconia Capital and EDBi. An additional US$50 million was raised in 2018, lifting the round's total to US$130 million, according to a company spokesperson.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

National Cancer Centre Singapore teams up with Singapore Cancer Society to make genetic screening more accessibleSINGAPORE - The National Cancer Centre Singapore (NCCS) and the Singapore Cancer Society (SCS) have announced a partnership that aims to make cancer detection, prevention and treatment more accessible to patients who require financial aid.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Under one roof: S’pore Cancer Society, National Cancer Centre join forces to provide ‘holistic care’
Source: TODAYonline - 🏆 1. / 99 Read more »

Sully, George HW Bush's dog, starts new job with wounded US service members, veteransLifting his thick paw to shake, former President George H.W. Bush's service dog took an oath to serve at Walter Reed National Medical Center on ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »